Element acquires Impact Analytical to expand North American life sciences testing footprint
- Element Materials Technology acquired Impact Analytical, expanding its North American life sciences testing footprint.
- Impact Analytical is based in Midland, Michigan, serving pharma, medical device, consumer product, specialty chemicals markets, with strength in extractables and leachables.
- The deal adds bio-analytical testing capacity, complementing Element’s recent life sciences acquisitions of ALG and Avomeen.
- Impact Analytical holds FDA, EPA, DEA, GLP/GMP, ISO, MDARD accreditations, supporting regulated testing services across Element’s lab network.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Element Ventures published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.
